Literature DB >> 17135321

Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization.

Agneta S von Gegerfelt1, Margherita Rosati, Candido Alicea, Antonio Valentin, Patricia Roth, Jenifer Bear, Genoveffa Franchini, Paul S Albert, Norbert Bischofberger, Jean D Boyer, David B Weiner, Phillip Markham, Zimra R Israel, John H Eldridge, George N Pavlakis, Barbara K Felber.   

Abstract

Rhesus macaques chronically infected with highly pathogenic simian immunodeficiency virus (SIV) SIVmac251 were treated with antiretroviral drugs and vaccinated with combinations of DNA vectors expressing SIV antigens. Vaccination during therapy increased cellular immune responses. After the animals were released from therapy, the virus levels of 12 immunized animals were significantly lower (P = 0.001) compared to those of 11 animals treated with only antiretroviral drugs. Vaccinated animals showed a persistent increase in immune responses, thus indicating both a virological and an immunological benefit following DNA therapeutic vaccination. Several animals show a long-lasting decrease in viremia, suggesting that therapeutic vaccination may provide an additional benefit to antiretroviral therapy.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17135321      PMCID： PMC1797580          DOI： 10.1128/JVI.01990-06

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  New hope for an AIDS vaccine.

Authors:  Harriet L Robinson
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

2.  Immune control of HIV-1 after early treatment of acute infection.

Authors:  E S Rosenberg; M Altfeld; S H Poon; M N Phillips; B M Wilkes; R L Eldridge; G K Robbins; R T D'Aquila; P J Goulder; B D Walker
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

3.  Control of SIV rebound through structured treatment interruptions during early infection.

Authors:  F Lori; M G Lewis; J Xu; G Varga; D E Zinn; C Crabbs; W Wagner; J Greenhouse; P Silvera; J Yalley-Ogunro; C Tinelli; J Lisziewicz
Journal:  Science       Date:  2000-11-24       Impact factor: 47.728

4.  HIV pathogenesis: the first cut is the deepest.

Authors:  Louis J Picker; David I Watkins
Journal:  Nat Immunol       Date:  2005-05       Impact factor: 25.606

5.  DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.

Authors:  Margherita Rosati; Agneta von Gegerfelt; Patricia Roth; Candido Alicea; Antonio Valentin; Marjorie Robert-Guroff; David Venzon; David C Montefiori; Phil Markham; Barbara K Felber; George N Pavlakis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.

Authors:  R Pal; D Venzon; N L Letvin; S Santra; D C Montefiori; N R Miller; E Tryniszewska; M G Lewis; T C VanCott; V Hirsch; R Woodward; A Gibson; M Grace; E Dobratz; P D Markham; Z Hel; J Nacsa; M Klein; J Tartaglia; G Franchini
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology.

Authors:  J W Romano; R N Shurtliff; E Dobratz; A Gibson; K Hickman; P D Markham; R Pal
Journal:  J Virol Methods       Date:  2000-04       Impact factor: 2.014

8.  Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques.

Authors:  Z Hel; D Venzon; M Poudyal; W P Tsai; L Giuliani; R Woodward; C Chougnet; G Shearer; J D Altman; D Watkins; N Bischofberger; A Abimiku; P Markham; J Tartaglia; G Franchini
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

9.  A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.

Authors:  Zdenek Hel; Julie M Johnson; Elzbieta Tryniszewska; Wen-Po Tsai; Robert Harrod; Jake Fullen; Jim Tartaglia; Genoveffa Franchini
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

10.  Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination.

Authors:  Martin Markowitz; Xia Jin; Arlene Hurley; Viviana Simon; Bharat Ramratnam; Michael Louie; Geoffrey R Deschenes; Murugappan Ramanathan; Shady Barsoum; Jeroen Vanderhoeven; Tian He; Chris Chung; John Murray; Alan S Perelson; Linqi Zhang; David D Ho
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226
View more
  27 in total

1.  Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.

Authors:  Vainav Patel; Antonio Valentin; Viraj Kulkarni; Margherita Rosati; Cristina Bergamaschi; Rashmi Jalah; Candido Alicea; Jacob T Minang; Matthew T Trivett; Claes Ohlen; Jun Zhao; Marjorie Robert-Guroff; Amir S Khan; Ruxandra Draghia-Akli; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

2.  Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus.

Authors:  Rob J De Boer
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

3.  Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Authors:  Viraj Kulkarni; Margherita Rosati; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Cristina Bergamaschi; Ashish K Singh; Candido Alicea; Bhabadeb Chowdhury; Gen-Mu Zhang; Eun-Young Kim; Steven M Wolinsky; Wensheng Huang; Yongjun Guan; Celia LaBranche; David C Montefiori; Kate E Broderick; Niranjan Y Sardesai; Antonio Valentin; Barbara K Felber; George N Pavlakis
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

4.  Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.

Authors:  Lauren A Hirao; Ling Wu; Amir S Khan; David A Hokey; Jian Yan; Anlan Dai; Michael R Betts; Ruxandra Draghia-Akli; David B Weiner
Journal:  Vaccine       Date:  2008-03-11       Impact factor: 3.641

5.  DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge.

Authors:  Margherita Rosati; Cristina Bergamaschi; Antonio Valentin; Viraj Kulkarni; Rashmi Jalah; Candido Alicea; Vainav Patel; Agneta S von Gegerfelt; David C Montefiori; David J Venzon; Amir S Khan; Ruxandra Draghia-Akli; Koen K A Van Rompay; Barbara K Felber; George N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

Review 6.  Synthetic DNA vaccine strategies against persistent viral infections.

Authors:  Daniel O Villarreal; Kendra T Talbott; Daniel K Choo; Devon J Shedlock; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2013-05       Impact factor: 5.217

7.  DNA prime/protein boost vaccination elicits robust humoral response in rhesus macaques using oligomeric simian immunodeficiency virus envelope and Advax delta inulin adjuvant.

Authors:  Veena Menon; Victor I Ayala; Sneha P Rangaswamy; Irene Kalisz; Stephen Whitney; Lindsey Galmin; Asma Ashraf; Celia LaBranche; David Montefiori; Nikolai Petrovsky; Vaniambadi S Kalyanaraman; Ranajit Pal
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

8.  DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.

Authors:  Xintao Hu; Antonio Valentin; Frances Dayton; Viraj Kulkarni; Candido Alicea; Margherita Rosati; Bhabadeb Chowdhury; Rajeev Gautam; Kate E Broderick; Niranjan Y Sardesai; Malcolm A Martin; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

9.  Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS.

Authors:  Monica Vaccari; Rabih Halwani; L Jean Patterson; Adriano Boasso; Jennifer Beal; Elzbieta Tryniszewska; Anna Hryniewicz; David Venzon; Elias K Haddad; Mohamed El-Far; Margherita Rosati; George N Pavlakis; Barbara K Felber; Saleh Al-Muhsen; Marjorie Robert-Guroff; Rafick-Pierre Sekaly; Genoveffa Franchini
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency.

Authors:  Chih-Ping Mao; Chien-Fu Hung; Tae Heung Kang; Liangmei He; Ya-Chea Tsai; Chao-Yi Wu; T-C Wu
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.